Molecular Partners
MOLN
4 hedge funds and large institutions have $14.2M invested in Molecular Partners in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0.01% more ownership
Funds ownership: 8.89% → 8.9% (+0.01%)
8% less capital invested
Capital invested by funds: $15.6M → $14.2M (-$1.32M)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
SmartHarvest Portfolios
Poulsbo,
Washington
|
+$14.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.52K |
| 2 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$105 |
MOLN Hedge Fund Activity: Q1 2026 in Review
4 of the 8,183 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q1 2026, worth a combined $14.2M — down 8.5% from $15.6M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MOLN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was SmartHarvest Portfolios, adding an estimated $14.4K. The largest seller was UBS Group, exiting entirely with an estimated $1.52K sold.
- 4 institutional investors held Molecular Partners (MOLN) as of Q1 2026, down from 6 in Q4 2025.
- Funds reported $14.2M of Molecular Partners stock for Q1 2026, down 8.5% quarter-over-quarter.
- 0 funds opened new Molecular Partners positions in Q1 2026 and 2 closed out, a net change of -2 holders.
- The largest Molecular Partners buyer in Q1 2026 was SmartHarvest Portfolios, an estimated $14.4K added.
- The largest Molecular Partners seller in Q1 2026 was UBS Group, an estimated $1.52K sold.
Based on aggregated 13F filings for Q1 2026.